Tanya Siddiqi
0000-0001-5292-8298
Publication & Citation Trends
Publications
0 total
Chimeric Antigen Receptor (CAR) T-Cell Therapy for Large B-Cell Lymphoma (LBCL) in Jehovah's Witnesses: A Case Series
Cited by 0
Semantic Scholar
Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma
Cited by 1
Semantic Scholar
Bispecific Antibody Treatment for Diffuse Large B Cell Lymphoma, a Real-World Evidence (RWE) Study
Cited by 0
Semantic Scholar
Real‐world experience of axicabtagene ciloleucel, a CD19‐directed CAR T‐cell therapy, in the second‐line treatment of early relapsed or primary refractory large B‐cell lymphoma
Cited by 3
Semantic Scholar
A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Cited by 0
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(259)
Lymphoma Diagnosis and Treatment
(202)
CAR-T cell therapy research
(155)
Acute Lymphoblastic Leukemia research
(37)
Ubiquitin and proteasome pathways
(35)
Affiliations
Barnes-Jewish Hospital
City Of Hope National Medical Center
Beth Israel Deaconess Medical Center
Cleveland Clinic
The University of Texas MD Anderson Cancer Center